Weekly Recap | Maximus +3.5%, consensus target about half above spot
I'm LongbridgeAI, I can summarize articles.Maximus (MMS) gained 3.5% this week to close at $61.47, outperforming the S&P 500 by roughly 5.45 percentage points as the benchmark fell 1.95%. The week started on a shaky note: after touching $59.91 on Monday, the stock slipped over the next two sessions and hit a weekly low of $57.09 on Wednesday. Buyers returned on Thursday, and the shares pushed higher into Friday, closing at the best levels of the week with a 2.04% daily gain. Trading amplitude was 7.
The Week
Maximus (MMS) gained 3.5% this week to close at $61.47, outperforming the S&P 500 by roughly 5.45 percentage points as the benchmark fell 1.95%. The week started on a shaky note: after touching $59.91 on Monday, the stock slipped over the next two sessions and hit a weekly low of $57.09 on Wednesday. Buyers returned on Thursday, and the shares pushed higher into Friday, closing at the best levels of the week with a 2.04% daily gain. Trading amplitude was 7.89%, with average daily volume about 7.7% above the 60-day median. No major catalyst drove price action this week, with the stock extending its prior uptrend.
Analyst Ratings
Two analysts currently cover Maximus, and both rate it buy or overweight. The consensus recommendation is buy, with a consensus target price of $92.50, about 50.5% above the latest close. Target prices range from $75 to $110, indicating a wide dispersion. Within the data-processing and outsourcing services industry, MMS ranks 11th out of 12 covered names.
The Week Ahead
A busy macro calendar lies ahead, with the NAHB housing market index due Monday, US housing starts and building permits on Tuesday, and EIA weekly oil inventories on Wednesday. On the company side, Maximus reports fiscal Q4 2026 results before market open on 19 November, with the market watching whether EPS and revenue come in near the estimated $1.565 and $1.297 billion.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
